Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2023-08-22 | 2024-01-30 | 202687 |
| SERTRALINE | 50MG | CAPSULE | Actual shortage | 2024-01-17 | 2024-01-30 | 216267 |
| RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Actual shortage | 2024-01-17 | 2024-01-30 | 216283 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-31 | 2024-01-30 | 200443 |
| LACOSAMIDE | 150MG | TABLET | Resolved | 2023-11-22 | 2024-01-30 | 211034 |
| MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-07-05 | 2024-01-30 | 197632 |
| ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-01-30 | 2024-02-09 | 217837 |
| SOLIFENACIN | 10MG | TABLET | Resolved | 2023-07-31 | 2024-02-12 | 200459 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-10-23 | 2024-02-12 | 207885 |
| MYCOPHENOLATE MOFETIL | 500MG | TABLET | Resolved | 2024-01-30 | 2024-02-13 | 217798 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-02-13 | 216259 |
| CARVEDILOL | 6.25MG | TABLET | Resolved | 2024-01-30 | 2024-02-13 | 217832 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172266 |
| AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-11-08 | 2024-02-14 | 173943 |
| PERINDOPRIL ERBUMINE | 8MG | TABLET | Resolved | 2024-01-17 | 2024-02-15 | 216247 |
| ROPINIROLE | 1MG | TABLET | Avoided shortage | 2021-09-24 | 2024-02-15 | 146199 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-10-08 | 2024-02-15 | 146947 |
| PREGABALIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-02-21 | 211065 |
| OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-01-14 | 2024-02-27 | 103271 |
| SERTRALINE | 50MG | CAPSULE | Actual shortage | 2024-02-26 | 2024-02-27 | 220643 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
| SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |